Rebecca Price
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rebecca Price sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Rebecca Price: 7 sponsored US clinical trials, 1 recruiting.
Rebecca Price sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 2 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 2 trials.
Upper-quartile sponsor footprint
Rebecca Price sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Apimostinel + Automated Neurocognitive Training for Depression
NCT06400121
Ketamine + Cognitive Training for Suicidality in the Medical Setting
NCT04578938
Ketamine + Mindfulness for Depression
NCT05168735
Repeated Neurocognitive Measurements in Depressed Patients
NCT04916548
Theta Burst Stimulation Plus Habit Override Training for Compulsive Behaviors
NCT04580043
Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
NCT04154150
Intravenous Ketamine Plus Neurocognitive Training for Depression
NCT03237286
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 1 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the Rebecca Price pipeline
1 recruiting of 7 indexed (14% open); 4 completed (57%).
Phase mix: 2 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Depression (2 trials), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rebecca Price: open-pipeline peers nationwide
Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Rebecca Price sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Rebecca Price page
7 registered trials is a research-attention snapshot, not an endorsement of Rebecca Price or any single study.
- 1 of Rebecca Price's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Rebecca Price studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Rebecca Price pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.